MC1418A1 - 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances - Google Patents

2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances

Info

Publication number
MC1418A1
MC1418A1 MC811560A MC1560A MC1418A1 MC 1418 A1 MC1418 A1 MC 1418A1 MC 811560 A MC811560 A MC 811560A MC 1560 A MC1560 A MC 1560A MC 1418 A1 MC1418 A1 MC 1418A1
Authority
MC
Monaco
Prior art keywords
pyrimidines
diamino
substances
preparation
medicines containing
Prior art date
Application number
MC811560A
Other languages
English (en)
Inventor
Susan Mary Daluge
Paul Marcel Skonezny
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MC1418A1 publication Critical patent/MC1418A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
MC811560A 1980-11-11 1981-11-10 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances MC1418A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8036135 1980-11-11

Publications (1)

Publication Number Publication Date
MC1418A1 true MC1418A1 (fr) 1982-10-18

Family

ID=10517217

Family Applications (1)

Application Number Title Priority Date Filing Date
MC811560A MC1418A1 (fr) 1980-11-11 1981-11-10 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances

Country Status (35)

Country Link
US (4) US4438267A (fr)
EP (1) EP0051879B1 (fr)
JP (1) JPS57114581A (fr)
KR (1) KR880001736B1 (fr)
AR (1) AR245447A1 (fr)
AU (1) AU549449B2 (fr)
CA (1) CA1186310A (fr)
CS (1) CS273153B2 (fr)
CY (1) CY1419A (fr)
DD (1) DD201896A5 (fr)
DE (1) DE3173752D1 (fr)
DK (1) DK172884B1 (fr)
EG (1) EG16107A (fr)
ES (5) ES8307759A1 (fr)
FI (1) FI76333C (fr)
GB (1) GB2087881B (fr)
GR (1) GR81317B (fr)
HK (1) HK23388A (fr)
HU (1) HU188762B (fr)
IE (1) IE52128B1 (fr)
IL (1) IL64256A (fr)
IT (1) IT1210589B (fr)
MC (1) MC1418A1 (fr)
MY (1) MY8600678A (fr)
NO (2) NO160137C (fr)
NZ (1) NZ198932A (fr)
PH (2) PH25053A (fr)
PL (4) PL139827B1 (fr)
PT (1) PT73960B (fr)
RU (1) RU1819264C (fr)
SG (1) SG62686G (fr)
SU (4) SU1424732A3 (fr)
YU (5) YU42444B (fr)
ZA (1) ZA817780B (fr)
ZM (1) ZM9481A1 (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
ZA833067B (en) * 1982-05-01 1984-12-24 Wellcome Found Antibacterial compounds
US4590271A (en) * 1982-05-01 1986-05-20 Burroughs Wellcome Co. 2,4-diamino-5-(substituted)pyrimidines, useful as antimicrobials
DK190983A (da) * 1982-05-01 1983-11-02 Wellcome Found 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor
US4587341A (en) * 1982-05-07 1986-05-06 Burroughs Wellcome Co. 2,4-diamino-5-(1,2,3,4-tetrahydro-(substituted or unsubstituted)-6-quinolylmethyl)pyrimidines, useful as antimicrobials
CA1244028A (fr) * 1983-04-14 1988-11-01 Hans Maag Derives de pyrimidine
GB8603964D0 (en) * 1986-02-18 1986-03-26 Cooper Animal Health Ltd Compositions
GB8603962D0 (en) * 1986-02-18 1986-03-26 Wellcome Found Chemical compositions
LU86703A1 (fr) * 1986-12-08 1988-07-14 Oreal Composition cosmetique photostable contenant un filtre uv-a et un filtre uv-b,son utilisation pour la protection de la peau contre les rayons uv et procede de stabilisation du filtre uv-a par le filtre uv-b
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.
GB8903978D0 (en) * 1989-02-22 1989-04-05 Coopers Animal Health Chemical compositions
GB9000241D0 (en) * 1990-01-05 1990-03-07 Coopers Animal Health Pharmaceutical use
RU95113597A (ru) * 1992-12-02 1997-06-10 ФМК Корпорейшн (US) Инсектицидная композиция, способы борьбы с насекомыми
US5707996A (en) * 1995-11-06 1998-01-13 Macleod Pharmaceuticals, Inc. Pharmaceutical solution and methods for preparation thereof
ES2169272T3 (es) * 1995-12-04 2002-07-01 Arpida Ag Diaminopirimidinas, composiciones farmaceuticas que las contienen y su utilizacion como agente antibacteriano.
WO2002010156A1 (fr) * 2000-07-29 2002-02-07 Arpida Ag Derives de benzofuranne et leur utilisation en tant qu'agents antibacteriens
US7700610B2 (en) * 2001-06-29 2010-04-20 Ab Science Use of tyrosine kinase inhibitors for treating allergic diseases
EP1434991B1 (fr) * 2001-06-29 2007-10-17 AB Science Nouveaux inhibiteurs selectifs puissants et non toxiques de c-kit
PT1401415E (pt) * 2001-06-29 2006-09-29 Ab Science Utilizacao de derivados de n-fenil-2-pirimidino-amina para o tratamento de doencas inflamatorias
ATE343415T1 (de) 2001-06-29 2006-11-15 Ab Science Die verwendung von c-kit hemmer zur behandlung von entzündlichen darmerkrankungen
EP1427379B1 (fr) * 2001-09-20 2008-08-13 AB Science Utilisation d'inhibiteurs c-kit puissants, selectifs et non toxiques pour le traitement de la cystopathie interstitielle
EP1450775B1 (fr) * 2001-09-20 2008-03-12 AB Science Inhibiteurs de c-kit pour traiter des infections bacteriennes
DE60227701D1 (de) * 2001-09-20 2008-08-28 Ab Science Die verwendung von c-kithemmern zur förderung des haarwuchses
WO2005005418A1 (fr) * 2003-07-11 2005-01-20 Arpida Ag Derives de benzofurane et leur utilisation dans le traitement d'infections microbiennes
EE200700051A (et) * 2005-02-18 2007-12-17 Arpida Ag Meetod 2H-kromeeni valmistamiseks ning vahehendid
EP1924565B1 (fr) * 2005-09-01 2016-09-14 F.Hoffmann-La Roche Ag Diaminopyrimidines en tant que modulateurs de p2x3 et p3x2/3
WO2010003084A2 (fr) * 2008-07-02 2010-01-07 Memory Pharmaceuticals Corporation Inhibiteurs de la phosphodiestérase 4
EP2440533B1 (fr) * 2009-06-12 2015-09-23 Socpra-Sciences Et Génie S.E.C. Composés se liant à un ribocommutateur guanine et leur utilisation en tant qu'antibiotiques
CN102649786B (zh) * 2011-02-28 2014-08-27 郑州福源动物药业有限公司 一种2，4-二氨基-5-(8-二甲氨基-7-甲基-5-喹啉基甲基)-2，4-(1h，3h)嘧啶的制备方法
CN103755684B (zh) * 2014-02-10 2015-09-09 青岛蔚蓝生物股份有限公司 一种巴喹普林的制备方法
CN113924293B (zh) * 2019-06-06 2024-07-09 北京泰德制药股份有限公司 P2x3和/或p2x2/3受体拮抗剂、包含其的药物组合物及其用途
CN110818694B (zh) * 2019-11-18 2023-04-21 上海医药工业研究院有限公司 艾拉普林中间体及其应用
WO2022217295A1 (fr) * 2021-04-09 2022-10-13 The Trustees Of The University Of Pennsylvania Régulation de l'expression protéique avec des composés de tmp-protac

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
US3956327A (en) * 1969-03-06 1976-05-11 Burroughs Wellcome Co. Method of preparing 2,4-diamino-5-benzyl pyrimidines
BE792096A (fr) * 1971-12-01 1973-05-30 Hoffmann La Roche Nouvelles benzylpyrimidines
GB1468374A (en) 1974-03-06 1977-03-23 Wellcome Found Process for preparing a pyrimidine derivative
US4039543A (en) 1974-12-24 1977-08-02 Hoffmann-La Roche Inc. Benzylpyrimidines
GB1582245A (en) * 1976-06-09 1981-01-07 Wellcome Found Benzyl cyanoacetal derivatives and their conversion to pyrimidine derivatives
DE2730467A1 (de) * 1977-07-06 1979-01-18 Basf Ag Benzylpyrimidine, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4258045A (en) * 1979-11-30 1981-03-24 Merck & Co., Inc. Inhibitor of dihydrofolate reductase
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use

Also Published As

Publication number Publication date
NO1994029I1 (no) 1994-12-29
DE3173752D1 (en) 1986-03-20
GB2087881A (en) 1982-06-03
ES521204A0 (es) 1984-06-01
PH22654A (en) 1988-10-28
IT8149676A0 (it) 1981-11-10
IL64256A0 (en) 1982-02-28
NZ198932A (en) 1985-05-31
PL139427B1 (en) 1987-01-31
ES8405380A1 (es) 1984-06-01
US4603136A (en) 1986-07-29
NO160137B (no) 1988-12-05
IE52128B1 (en) 1987-06-24
KR830007628A (ko) 1983-11-04
SU1424732A3 (ru) 1988-09-15
YU266381A (en) 1984-04-30
YU42444B (en) 1988-08-31
EP0051879B1 (fr) 1986-02-05
YU46697B (sh) 1994-04-05
HK23388A (en) 1988-04-08
SU1318148A3 (ru) 1987-06-15
ES521203A0 (es) 1984-06-01
PL139523B1 (en) 1987-01-31
YU144288A (en) 1990-04-30
FI813546L (fi) 1982-05-12
NO160137C (no) 1989-03-15
ZA817780B (en) 1983-06-29
YU198383A (en) 1984-04-30
EG16107A (en) 1987-10-30
AU7733481A (en) 1982-05-20
CA1186310A (fr) 1985-04-30
US4438267A (en) 1984-03-20
ES8405379A1 (es) 1984-06-01
NO813804L (no) 1982-05-12
SU1535379A3 (ru) 1990-01-07
ES506969A0 (es) 1983-07-01
ZM9481A1 (en) 1983-11-21
PL139827B1 (en) 1987-02-28
CS825781A2 (en) 1990-07-12
HU188762B (en) 1986-05-28
US4587342A (en) 1986-05-06
IT1210589B (it) 1989-09-14
PL233754A1 (en) 1983-08-01
EP0051879A2 (fr) 1982-05-19
ES8405377A1 (es) 1984-06-01
YU198283A (en) 1984-04-30
RU1819264C (ru) 1993-05-30
ES8405378A1 (es) 1984-06-01
SG62686G (en) 1987-03-27
ES8307759A1 (es) 1983-07-01
YU198183A (en) 1984-04-30
IE812631L (en) 1982-05-11
JPH0474351B2 (fr) 1992-11-26
PT73960B (en) 1983-11-23
CY1419A (en) 1988-04-22
PH25053A (en) 1991-01-28
PL139828B1 (en) 1987-02-28
PL239280A1 (en) 1983-08-01
IL64256A (en) 1988-01-31
YU43551B (en) 1989-08-31
AR245447A1 (es) 1994-01-31
ES521202A0 (es) 1984-06-01
FI76333B (fi) 1988-06-30
KR880001736B1 (ko) 1988-09-10
DK496681A (da) 1982-05-12
FI76333C (fi) 1988-10-10
PL239278A1 (en) 1983-08-01
CS273153B2 (en) 1991-03-12
GR81317B (fr) 1984-12-11
EP0051879A3 (en) 1982-08-04
PT73960A (en) 1981-12-01
DD201896A5 (de) 1983-08-17
PL239279A1 (en) 1983-08-01
ES521201A0 (es) 1984-06-01
US4761475A (en) 1988-08-02
DK172884B1 (da) 1999-09-06
AU549449B2 (en) 1986-01-30
MY8600678A (en) 1986-12-31
JPS57114581A (en) 1982-07-16
GB2087881B (en) 1985-05-15
SU1306473A3 (ru) 1987-04-23

Similar Documents

Publication Publication Date Title
MC1418A1 (fr) 2,4-diamino-pyrimidines,leur preparation et medicaments contenant ces substances
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
BE855405A (fr) Nouvelles 4-amino-4-arylcyclohexanones, leur procede de preparation et medicament les contenant
FR2334359A1 (fr) Derives de l'isoquinoleine, leur preparation et medicaments contenant ces substances
BE860726A (fr) Nouveaux aryl-acylamides n-(2-aminocy-cloaliphatiques), leur procede de preparation et medicament les contenant
BE884077A (fr) Nouveaux tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
FR2473884B1 (fr) Associations d'une halogeno-propiophenone et d'une diazepine, medicaments tranquillisants contenant de telles associations, et leur preparation
BE894175A (fr) Nouvelles imidazotetrazinones, leur preparation et les medicaments qui les contiennent.
BE865015A (fr) Pseudotrisaccharides, leur procede de preparation et medicament les contenant
FR2338936A1 (fr) Nouvelles 1,2-benzisothiazolinones-3, leur procede de preparation et medicament les contenant
BE858269A (fr) Nouvelles aminoalkylidenamino-1,4-dihydropyridines, leur procede de preparation et medicament les contenant
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
BE869166A (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
BE884075A (fr) Nouveaux dipeptides, leur preparation et les medicaments qui les contiennent
FR2331349A1 (fr) Benzodiazepines, leur preparation et medicament contenant ces substances
BE862278A (fr) Nouveaux composes heterocycliques, leur procede de preparation et medicament les contenant
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
FR2496100B1 (fr) Derives de la pyrazoline, leur preparation et medicaments contenant ces substances
BE884076A (fr) Nouveaux tripeptides, leur preparation et les medicaments qui les contiennent
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
FR2346354A1 (fr) Nouvelles as-triazinobenzodiazepine-1-ones, leur procede de preparation et medicament les contenant
FR2468598B1 (fr) Thiazolidones-4 substituees en 2, leur procede de preparation et les medicaments les contenant
BE892635A (fr) Mercapto acyl-carnitines, leur preparation et compositions pharmaceutiques en contenant
BE848385A (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant,
BE895957A (fr) Nouveaux derives de la 1,4-dihydropyridine, leur preparation et medicaments contenant ces derives

Legal Events

Date Code Title Description
YP Annual fee paid